Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks
Crossref DOI link: https://doi.org/10.1007/s40261-014-0266-2
Published Online: 2015-01-31
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quercia, Romina
Roberts, Jeremy
Martin-Carpenter, Louise
Zala, Carlos
License valid from 2015-01-31